Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$737M |
| 2 |
Invesco S&P 500 Revenue ETF
RWL
|
+$669M |
| 3 |
Bank of America
BAC
|
+$513M |
| 4 |
Amazon
AMZN
|
+$510M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$482M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$491M |
| 2 |
Trade Desk
TTD
|
+$466M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$373M |
| 4 |
Eli Lilly
LLY
|
+$367M |
| 5 |
Williams-Sonoma
WSM
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Purple Innovation
PRPL
$34.5M
| $148K | ﹤0.01% |
7,808
-2,483
| -24% | -$57.2K |
|
|
SVM
3502
Silvercorp Metals
SVM
$2.02B
| $148K | ﹤0.01% |
38,242
-11,060
| -22% | -$38.9K |
|
|
BBBY
3503
Bed Bath & Beyond
BBBY
$479M
| $148K | ﹤0.01% |
28,050
-848,040
| -97% | -$5.15M |
|
|
SEMR
3504
DELISTED
Semrush
SEMR
| $145K | ﹤0.01% |
15,498
-577
| -4% | -$7.87K |
|
|
LUCK
3505
Lucky Strike Entertainment
LUCK
$959M
| $144K | ﹤0.01% |
+14,786
| New | +$155K |
|
|
YMAB
3506
DELISTED
Y-mAbs Therapeutics
YMAB
| $144K | ﹤0.01% |
32,547
+17,624
| +118% | +$102K |
|
3507
Zevra Therapeutics
ZVRA
$578M
| $142K | ﹤0.01% |
19,022
+638
| +3% | +$5.07K |
|
3508
Aemetis
AMTX
$99.2M
| $141K | ﹤0.01% |
81,256
+64,115
| +374% | +$137K |
|
|
WW
3509
DELISTED
WW International
WW
| $141K | ﹤0.01% |
269,910
-79,527
| -23% | -$69.1K |
|
3510
Acumen Pharmaceuticals
ABOS
$152M
| $141K | ﹤0.01% |
127,798
+107,956
| +544% | +$154K |
|
3511
UroGen Pharma
URGN
$1.97B
| $141K | ﹤0.01% |
12,710
-746
| -6% | -$7.95K |
|
3512
Evolv Technologies
EVLV
$998M
| $137K | ﹤0.01% |
43,866
-2,203
| -5% | -$7.73K |
|
3513
Noodles & Co
NDLS
$95.1M
| $136K | ﹤0.01% |
15,641
-2,509
| -14% | -$24.7K |
|
3514
Capricor Therapeutics
CAPR
$380M
| $135K | ﹤0.01% |
14,248
-430
| -3% | -$5.97K |
|
3515
Immersion
IMMR
$243M
| $135K | ﹤0.01% |
17,796
-825
| -4% | -$6.77K |
|
|
VTYX
3516
DELISTED
Ventyx Biosciences
VTYX
| $135K | ﹤0.01% |
117,062
-28,562
| -20% | -$49K |
|
|
TGB
3517
Trekor Metals
TGB
$2.45B
| $134K | ﹤0.01% |
59,862
-16,992
| -22% | -$36.1K |
|
3518
Ocugen
OCGN
$403M
| $133K | ﹤0.01% |
188,678
+15,125
| +9% | +$10.5K |
|
3519
CarParts.com
PRTS
$42.6M
| $132K | ﹤0.01% |
13,248
-4,405
| -25% | -$48.3K |
|
3520
Lexicon Pharmaceuticals
LXRX
$1.03B
| $132K | ﹤0.01% |
285,759
+181,265
| +173% | +$114K |
|
3521
MaxCyte
MXCT
$108M
| $128K | ﹤0.01% |
46,841
-2,255
| -5% | -$8.89K |
|
|
BGFV
3522
DELISTED
Big 5 Sporting Goods
BGFV
| $128K | ﹤0.01% |
132,220
-35,658
| -21% | -$48.8K |
|
3523
Nkarta
NKTX
$152M
| $128K | ﹤0.01% |
69,396
+57,399
| +478% | +$118K |
|
3524
Quantum-Si Incorporated
QSI
$153M
| $124K | ﹤0.01% |
103,657
+66,336
| +178% | +$127K |
|
3525
SkinHealth Systems
SKIN
$83.4M
| $124K | ﹤0.01% |
92,368
-51
| -0.1% | -$78 |
|
Similar funds
Invesco's Q1 2025 Portfolio in Review
As of Q1 2025, Invesco held 3,856 positions worth $528B, down 2.4% from $541B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2025 filing shows 117 new, 1,793 increased, 1,749 reduced and 89 closed positions. Its largest new stake was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $491M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2025 buy was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M.
- Invesco added most to Tesla in Q1 2025, an estimated $737M increase.
- Invesco's biggest Q1 2025 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $491M.
- Invesco fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $281M.
- Invesco's ten largest holdings make up 17% of its $528B portfolio in Q1 2025.
- Invesco opened 117 new positions and closed 89 in Q1 2025.
- Invesco's portfolio value fell 2.4% quarter-over-quarter to $528B.
Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.